Milestone Pharmaceuticals Inc.’s CARDAMYST nasal spray wins FDA approval for PSVT, but faces tough competition and market ...

Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics. Click here to read our picks.

You've probably seen movies where life-threatening events unfold in slow motion. Those moments during a car crash or a fall ...

Lina Mockus, ND Emerging research reveals that gut-derived inflammation, microbial metabolites, and metabolic dysfunction ...

Propranolol — once reserved for heart problems — is now helping people survive grocery stores, medical offices, breakup chats ...

Two NEJM trials report conflicting results on long-term beta-blockers after MI in patients with preserved ejection fraction, ...

The heart medication can ease physical symptoms of panic, making them popular for job interviews, public speaking events and ...

Details of a new UK clinical trial to assess the risks and benefits of puberty-blocking drugs in children who question their gender have been announced. It follows the banning of the drugs for gender ...

New Zealand has become the latest country to announce that it will halt new prescriptions for puberty blockers for young people with gender dysphoria. While young people who currently have a ...

The study presents convincing quantitative evidence, supported by appropriate negative controls, for the presence of low-abundance glycine receptors (GlyRs) within inhibitory synapses in telencephalic ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...